Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition

Prostate cancer is a common form of cancer in men, and androgen-deprivation therapy (ADT) is often used as a first-line treatment. However, some patients develop resistance to ADT, and their disease is called castration-resistant prostate cancer (CRPC). Identifying potential therapeutic targets for...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Hyunho, Park, Cheol Keun, Choi, Young-Deuk, Cho, Nam Hoon, Lee, Jongsoo, Cho, Kang Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855385/
https://www.ncbi.nlm.nih.gov/pubmed/36672609
http://dx.doi.org/10.3390/biomedicines11010101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855385/
https://www.ncbi.nlm.nih.gov/pubmed/36672609
http://dx.doi.org/10.3390/biomedicines11010101

Ejemplares similares